Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Basit Öğe Kaydı
dc.authorid0000-0001-7306-5233en_US
dc.authorid0000-0002-3172-8200en_US
dc.authorid0000-0002-3836-2125
dc.authorid0000-0002-3172-8200
dc.contributor.authorAktaş, Gülali
dc.contributor.authorDuman, Tuba Taslamacıoğlu
dc.contributor.authorAtak, Burçin
dc.contributor.authorKurtkulağı, Özge
dc.contributor.authorBilgin, Satılmış
dc.contributor.authorBaşaran, Elif
dc.contributor.authorDemirkol, Muhammed Emin
dc.contributor.authorKösekli, Mehmet Ali
dc.date.accessioned2021-06-23T19:54:48Z
dc.date.available2021-06-23T19:54:48Z
dc.date.issued2020
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjectives. We aimed to study novel inflammatory markers derived from hemograms and to compare them to those in healthy subjects. Material and methods. The platelet distribution width (PDW), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) of patients with IBS were gathered from a database and compared to those in a healthy population. Results. The PLR of the IBS group (144 +/- 50%) was higher than the PLR of the control group (111 +/- 32%; p < 0.001). The PDW of the IBS group (16.3 [1%]) was higher than the PDW of the control group (15.4 [2.4%]; p < 0.001). The NLR of the IBS group (2.2 [1.1%]) was higher than the NLR of the control group (1.8 [0.7%]; p < 0.001). The MLR of the IBS group (0.25 [0.14%]) was higher than the MLR of the control group (0.2 [0.12%]; p < 0.001). Conclusions. We think that PDW, NLR, PLR, and MLR could all serve as diagnostic tools for IBS. Although the diagnosis of IBS is based on history and clinical findings, the simplicity and low cost of these hemogram tests could provide laboratory support in establishing a diagnosis, especially in suspected cases.en_US
dc.identifier.doi10.5114/fmpcr.2020.95311
dc.identifier.endpage110en_US
dc.identifier.issn1734-3402
dc.identifier.issn2449-8580
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85090610105en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage107en_US
dc.identifier.urihttps://doi.org/10.5114/fmpcr.2020.95311
dc.identifier.urihttps://hdl.handle.net/20.500.12491/10649
dc.identifier.volume22en_US
dc.identifier.wosWOS:000548736800002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorAktaş, Gülali
dc.institutionauthorDuman, Tuba Taslamacıoğlu
dc.institutionauthorDemirkol, Muhammed Emin
dc.institutionauthorKösekli, Mehmet Ali
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofFamily Medicine And Primary Care Reviewen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIrritable Bowel Syndromeen_US
dc.subjectInflammationen_US
dc.subjectBlood Plateletsen_US
dc.titleIrritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parametersen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
gulali-aktas.pdf
Boyut:
407.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu